Physician profile
Jessica Delong
NPI 1306017785
$577,831.77
in general payments reported to CMS, 2019-2025
23 companies · $318K in 2025
The $318K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,056 · 2020: $264 · 2021: $214 · 2022: $961 · 2023: $45K · 2024: $206K · 2025: $318K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $516K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Travel and Lodging: $5,891 · Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $515,662.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,735.98 |
| Travel and Lodging | $5,890.74 |
| Food and Beverage | $1,048.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $548,091.87 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $21,074.31 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $6,173.60 | 2019-2021 | |
| Urovant Sciences INC | $915.00 | 2022 | |
| Janssen Biotech, INC. | $324.37 | 2019-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $141.24 | 2019-2020 | |
| Allergan, INC. | $131.75 | 2019-2020 | |
| Medtronic USA, INC. | $125.85 | 2019 | |
| Progenics Pharmaceuticals, INC. | $109.38 | 2024 | |
| Coloplast Corp | $105.80 | 2019 | |
| Neotract INC. | $94.35 | 2019 | |
| Astellas Pharma US INC | $93.81 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $89.39 | 2019-2022 | |
| Axonics, INC. | $69.65 | 2021 | |
| Sun Pharmaceutical Industries INC. | $62.03 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $48.83 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.35 | 2019 | |
| Dendreon Pharmaceuticals LLC | $34.49 | 2019 | |
| Renovia INC | $31.49 | 2019 | |
| Antares Pharma, INC. | $23.25 | 2019 | |
| Medline Industries Lp | $16.87 | 2019 | |
| Olympus America INC. | $15.45 | 2020 | |
| Ambu INC. | $11.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Delong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.